% IMPORTANT: The following is UTF-8 encoded.  This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.

@ARTICLE{Hemminki:186485,
      author       = {K. Hemminki$^*$ and A. Försti$^*$ and V. Liska and A.
                      Kanerva and O. Hemminki and A. Hemminki},
      title        = {{L}ong-term survival trends in solid cancers in the
                      {N}ordic countries marking timing of improvements.},
      journal      = {International journal of cancer},
      volume       = {152},
      number       = {9},
      issn         = {0020-7136},
      address      = {Bognor Regis},
      publisher    = {Wiley-Liss},
      reportid     = {DKFZ-2022-03206},
      pages        = {1837-1846},
      year         = {2023},
      note         = {#EA:C020# / 2023 May 1;152(9):1837-1846},
      abstract     = {Survival studies are an important indicator of the success
                      of cancer control. We analyzed the 5-year relative survival
                      in 23 solid cancers in Denmark, Finland, Norway and Sweden
                      over a 50-year period (1970-2019) at the NORDCAN database
                      accessed from the International Agency for Research on
                      Cancer website. We plotted survival curves in 5-year periods
                      and showed 5-year periodic survival. The survival results
                      were summarized in 4 groups: 1) cancers with historically
                      good survival $(>50\%$ in 1970-74) which include melanoma
                      and breast, endometrial and thyroid cancers; 2) cancers
                      which constantly improved survival at least 20 $\%$ units
                      over the 50 year period, including cancers of the stomach,
                      colon, rectum, kidney, brain and ovary; 3) cancer with
                      increase in survival >20 $\%$ units with changes taking
                      place in a narrow time window, including oral,
                      oropharyngeal, testicular and prostate cancers; 4) the
                      remaining cancers with <20 $\%$ unit improvement in survival
                      including lung, esophageal, liver, pancreatic, bladder, soft
                      tissue, penile, cervical and vulvar cancers. For cancers in
                      groups 1 and 2, the constant development implied multiple
                      improvements in therapy, diagnosis and patient care. Cancers
                      in group 3 included testicular cancers with known
                      therapeutic improvements but for the others large incidence
                      changes probably implied that cancer stage (prostate) or
                      etiology (oropharynx) changed into a more tractable form.
                      Group 4 cancers included those with dismal survival 50 years
                      ago but a clear tendency upwards. In 17 cancers 5-year
                      survival reached between 50 and 100 $\%$ while in only 6
                      cancers it remained at below $50\%.$ This article is
                      protected by copyright. All rights reserved.},
      keywords     = {early diagnosis (Other) / periodic survival (Other) /
                      prognosis (Other) / relative survival (Other) / treatment
                      (Other)},
      cin          = {C020 / B062 / HD01},
      ddc          = {610},
      cid          = {I:(DE-He78)C020-20160331 / I:(DE-He78)B062-20160331 /
                      I:(DE-He78)HD01-20160331},
      pnm          = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
      pid          = {G:(DE-HGF)POF4-313},
      typ          = {PUB:(DE-HGF)16},
      pubmed       = {pmid:36571455},
      doi          = {10.1002/ijc.34416},
      url          = {https://inrepo02.dkfz.de/record/186485},
}